ERAMO ANNA enters LB PHARMACEUTICALS INC with 3.58K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/10/2025ACC: 0001415889-25-024173
Officer· Chief Medical Officer
Since Sep 2025
3.58K
Baseline shares
100% direct
3.58K
Direct ownership
1 position
33.17K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned3.58K
Total
3.58K direct3.58K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.58K | Direct |
| Total | 3.58K | 3.58K direct |
Derivative Holdings2
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
6.28K
Shares owned
N/A
Exercise price
41.84
Expiration
—
Exercise window
—
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
26.89K
Shares owned
N/A
Exercise price
41.84
Expiration
—
Exercise window
—
Total
Underlying
33.17K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock | 41.84 | — | — | 6.28K | N/A |
| Employee Stock Option (Right to Buy) Direct | Common Stock | 41.84 | — | — | 26.89K | N/A |
| Total | 33.17K | 0.00 | ||||